161 related articles for article (PubMed ID: 33792022)
21. Appraisal of systematic reviews on the management of peri-implant diseases with two methodological tools.
Faggion CM; Monje A; Wasiak J
J Clin Periodontol; 2018 Jun; 45(6):754-766. PubMed ID: 29575189
[TBL] [Abstract][Full Text] [Related]
22. The Cochrane risk of bias assessment tool 2 (RoB 2) versus the original RoB: A perspective on the pros and cons.
Nejadghaderi SA; Balibegloo M; Rezaei N
Health Sci Rep; 2024 Jun; 7(6):e2165. PubMed ID: 38835932
[TBL] [Abstract][Full Text] [Related]
23. Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane.
Flemyng E; Moore TH; Boutron I; Higgins JP; Hróbjartsson A; Nejstgaard CH; Dwan K
BMJ Evid Based Med; 2023 Aug; 28(4):260-266. PubMed ID: 36693715
[TBL] [Abstract][Full Text] [Related]
24. Knowledge user survey and Delphi process to inform development of a new risk of bias tool to assess systematic reviews with network meta-analysis (RoB NMA tool).
Lunny C; Veroniki AA; Hutton B; White I; Higgins J; Wright JM; Kim JY; Thirugnanasampanthar SS; Siddiqui S; Watt J; Moja L; Taske N; Lorenz RC; Gerrish S; Straus S; Minogue V; Hu F; Lin K; Kapani A; Nagi S; Chen L; Akbar-Nejad M; Tricco AC
BMJ Evid Based Med; 2023 Feb; 28(1):58-67. PubMed ID: 35948412
[TBL] [Abstract][Full Text] [Related]
25. In Cochrane reviews, risk of bias assessments for allocation concealment were frequently not in line with Cochrane's Handbook guidance.
Propadalo I; Tranfic M; Vuka I; Barcot O; Pericic TP; Puljak L
J Clin Epidemiol; 2019 Feb; 106():10-17. PubMed ID: 30312657
[TBL] [Abstract][Full Text] [Related]
26. Three risk of bias tools lead to opposite conclusions in observational research synthesis.
Losilla JM; Oliveras I; Marin-Garcia JA; Vives J
J Clin Epidemiol; 2018 Sep; 101():61-72. PubMed ID: 29864541
[TBL] [Abstract][Full Text] [Related]
27. Key concepts in clinical epidemiology: addressing and reporting sources of bias in randomized controlled trials.
Kotz D; West R
J Clin Epidemiol; 2022 Mar; 143():197-201. PubMed ID: 34571193
[TBL] [Abstract][Full Text] [Related]
28. The effect of the CONSORT statement on the amount of "unclear" Risk of Bias reporting in Cochrane Systematic Reviews.
Rademaker MM; Ramakers GGJ; Smit AL; Hooft L; Stegeman I
PLoS One; 2020; 15(7):e0235535. PubMed ID: 32650340
[TBL] [Abstract][Full Text] [Related]
29. Usability and sensitivity of the risk of bias assessment tool for randomized controlled trials of pharmacist interventions.
Tonin FS; Lopes LA; Rotta I; Bonetti AF; Pontarolo R; Correr CJ; Fernandez-Llimos F
Int J Clin Pharm; 2019 Jun; 41(3):785-792. PubMed ID: 30963446
[TBL] [Abstract][Full Text] [Related]
30. Are Neonatal Trials Better Conducted and Reported over the Last 6 Decades? An Analysis on Their Risk-of-Bias Status in Cochrane Reviews.
Lai NM; Ong JMJ; Chen KH; Chaiyakunapruk N; Ovelman C; Soll R
Neonatology; 2019; 116(2):123-131. PubMed ID: 31108494
[TBL] [Abstract][Full Text] [Related]
31. There were large discrepancies in risk of bias tool judgments when a randomized controlled trial appeared in more than one systematic review.
Jordan VM; Lensen SF; Farquhar CM
J Clin Epidemiol; 2017 Jan; 81():72-76. PubMed ID: 27622779
[TBL] [Abstract][Full Text] [Related]
32. Randomized controlled trials in patients with COVID-19: a systematic review and critical appraisal.
Kudhail K; Thompson J; Mathews V; Morrison B; Hemming K
Int J Infect Dis; 2022 Sep; 122():72-80. PubMed ID: 35597556
[TBL] [Abstract][Full Text] [Related]
33. In Cochrane nutrition reviews assessment of dietary adherence varied considerably.
Schwingshackl L; Stadelmaier J; Lay R; Griebler U; De Santis KK; Zeeb H; Kien C; Reimer M; Eble J; von Philipsborn P; Gerhardus A; von Elm E; Meerpohl JJ; Kiesswetter E
J Clin Epidemiol; 2023 Jun; 158():1-9. PubMed ID: 36965600
[TBL] [Abstract][Full Text] [Related]
34. Methodological quality and risk-of-bias assessments in systematic reviews of treatments for peri-implantitis.
Hasuike A; Ueno D; Nagashima H; Kubota T; Tsukune N; Watanabe N; Sato S
J Periodontal Res; 2019 Aug; 54(4):374-387. PubMed ID: 30671962
[TBL] [Abstract][Full Text] [Related]
35. Risk-of-bias assessment using Cochrane's revised tool for randomized trials (RoB 2) was useful but challenging and resource-intensive: observations from a systematic review.
Crocker TF; Lam N; Jordão M; Brundle C; Prescott M; Forster A; Ensor J; Gladman J; Clegg A
J Clin Epidemiol; 2023 Sep; 161():39-45. PubMed ID: 37364620
[TBL] [Abstract][Full Text] [Related]
36. Inter-rater reliability and validity of risk of bias instrument for non-randomized studies of exposures: a study protocol.
Jeyaraman MM; Al-Yousif N; Robson RC; Copstein L; Balijepalli C; Hofer K; Fazeli MS; Ansari MT; Tricco AC; Rabbani R; Abou-Setta AM
Syst Rev; 2020 Feb; 9(1):32. PubMed ID: 32051035
[TBL] [Abstract][Full Text] [Related]
37. RoB-SPEO: A tool for assessing risk of bias in studies estimating the prevalence of exposure to occupational risk factors from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury.
Pega F; Norris SL; Backes C; Bero LA; Descatha A; Gagliardi D; Godderis L; Loney T; Modenese A; Morgan RL; Pachito D; Paulo MBS; Scheepers PTJ; Schlünssen V; Sgargi D; Silbergeld EK; Sørensen K; Sutton P; Tenkate T; Torreão Corrêa da Silva D; Ujita Y; van Deventer E; Woodruff TJ; Mandrioli D
Environ Int; 2020 Feb; 135():105039. PubMed ID: 31864023
[TBL] [Abstract][Full Text] [Related]
38. Assessing the risk of performance and detection bias in Cochrane reviews as a joint domain is less accurate compared to two separate domains.
Barcot O; Boric M; Dosenovic S; Puljak L
BMC Med Res Methodol; 2021 Jul; 21(1):149. PubMed ID: 34275437
[TBL] [Abstract][Full Text] [Related]
39. Assessing the Risk of Bias in Randomized Clinical Trials With Large Language Models.
Lai H; Ge L; Sun M; Pan B; Huang J; Hou L; Yang Q; Liu J; Liu J; Ye Z; Xia D; Zhao W; Wang X; Liu M; Talukdar JR; Tian J; Yang K; Estill J
JAMA Netw Open; 2024 May; 7(5):e2412687. PubMed ID: 38776081
[TBL] [Abstract][Full Text] [Related]
40. Enhanced access to recommendations from the Cochrane Handbook for improving authors' judgments about risk of bias: A randomized controlled trial.
Barcot O; Ivanda M; Buljan I; Pieper D; Puljak L
Res Synth Methods; 2021 Sep; 12(5):618-629. PubMed ID: 34050603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
